{
  "id": 1888129,
  "title": "Symbiotec Pharmalab's ₹1,757 crore IPO to open on August 24",
  "url": "https://urgent.news/2026/08/19/symbiotec-pharmalabs-1-757-crore-ipo-to-open-on-august-24",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-19T07:12:50.000Z",
  "source": {
    "name": "Hindu BusinessLine",
    "slug": "hindu-businessline",
    "url": "https://www.thehindubusinessline.com/markets/symbiotec-pharmalabs-1757-crore-ipo-to-open-on-august-24/article71363483.ece"
  },
  "original_language": "en",
  "account": "Symbiotec Pharmalab Ltd, a pharmaceutical and biotech firm, is scheduled to launch its Initial Public Offering (IPO) on August 24. The company aims to raise ₹1,757 crore through a fresh issue and an Offer For Sale (OFS), with a price band set at ₹938-988 per equity share. This valuation places the company's worth at approximately ₹6,350 crore at the higher end. Subscriptions will close on August 27, while anchor investors will bid on August 21, according to the company's announcement. The IPO consists of a fresh equity issue of up to ₹150 crore and an OFS worth up to ₹1,607 crore. Promoter Satwani Holdings LLP and investors Rosewood Investments and India Business Excellence Fund-III will be selling shares through the OFS. The funds raised will be used for debt repayment and general corporate purposes. Symbiotec, based in Indore, is a research and development-focused company leveraging capabilities in organic chemistry, biotechnology, and complex injectables. Global in corticosteroid and steroidal-hormone APIs, the company will list its shares on both the BSE and NSE on September 1. Book-running lead managers include JM Financial, Avendus Capital, Motilal Oswal, and Nomura Financial, with MUFG Intime India Pvt Ltd serving as the registrar.",
  "summary": "The IPO will close for subscription on August 27, while bidding by anchor investors will take place on August 21, according to the company's announcement on Wednesday",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "The Economic Times - Top News",
        "title": "Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24",
        "url": "https://urgent.news/2026/08/19/symbiotec-pharmalab-sets-price-band-for-rs-1-757-crore-ipo-to-open-on",
        "published": "2026-08-19T03:34:57.000Z"
      },
      {
        "outlet": "Free Press Journal",
        "title": "Symbiotec Pharmalab To Launch ₹1,757-Crore IPO On August 24",
        "url": "https://urgent.news/2026/08/19/symbiotec-pharmalab-to-launch-1-757-crore-ipo-on-august-24",
        "published": "2026-08-19T06:34:57.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}